Behaviour

Human behaviour is being engineered in real time. GLP-1 drugs and biotech breakthroughs are recalibrating appetite, health, and inequality, reshaping industries from food to finance. Wealthy elites pursue billionaire upgrades, redefining what it means to age, thrive, or survive. Cultural influence is shifting too: cities designed by women propose radically different models of urban life, while accessibility beyond compliance insists on inclusion as a foundation rather than an afterthought. Health revolutions are emerging in the dark, transforming societies (and businesses) before norms and ethics can catch up. Behaviour is no longer organic; it is being coded, purchased, and redirected.